Samuel M. Levi

1.7k total citations
10 papers, 799 citations indexed

About

Samuel M. Levi is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Samuel M. Levi has authored 10 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Epidemiology. Recurrent topics in Samuel M. Levi's work include Autophagy in Disease and Therapy (3 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Samuel M. Levi is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Samuel M. Levi collaborates with scholars based in United States, Switzerland and Germany. Samuel M. Levi's co-authors include Eric N. Jacobsen, Jeffrey D. Winkler, Ravi K. Amaravadi, Quentin McAfee, Zhihui Zhang, Arabinda Samanta, Shengfu Piao, Takeshi Uehara, John P. Lynch and Lisa E. Davis and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Samuel M. Levi

10 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel M. Levi United States 10 465 361 299 114 73 10 799
William C. Trenkle United States 12 387 0.8× 133 0.4× 269 0.9× 60 0.5× 53 0.7× 18 776
Stanley D. Chamberlain United States 19 429 0.9× 185 0.5× 476 1.6× 42 0.4× 158 2.2× 35 1.0k
Jeroen C. Verheijen United States 21 1.0k 2.2× 90 0.2× 491 1.6× 17 0.1× 92 1.3× 36 1.4k
S.E. Greasley United States 19 726 1.6× 44 0.1× 165 0.6× 72 0.6× 153 2.1× 25 935
Tohru Obata Japan 16 320 0.7× 50 0.1× 144 0.5× 30 0.3× 180 2.5× 48 755
Iana M. Serafimova United States 7 665 1.4× 95 0.3× 346 1.2× 12 0.1× 136 1.9× 8 958
Dirk A. Heerding United States 15 484 1.0× 110 0.3× 358 1.2× 8 0.1× 75 1.0× 23 870
Xiujun Liu China 18 472 1.0× 58 0.2× 155 0.5× 18 0.2× 268 3.7× 61 832
Cuiting Peng China 16 395 0.8× 62 0.2× 215 0.7× 11 0.1× 80 1.1× 36 691

Countries citing papers authored by Samuel M. Levi

Since Specialization
Citations

This map shows the geographic impact of Samuel M. Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel M. Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel M. Levi more than expected).

Fields of papers citing papers by Samuel M. Levi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel M. Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel M. Levi. The network helps show where Samuel M. Levi may publish in the future.

Co-authorship network of co-authors of Samuel M. Levi

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel M. Levi. A scholar is included among the top collaborators of Samuel M. Levi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel M. Levi. Samuel M. Levi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Levi, Samuel M., et al.. (2022). Site-selective, stereocontrolled glycosylation of minimally protected sugars. Nature. 608(7921). 74–79. 81 indexed citations
2.
Vara, Brandon, Samuel M. Levi, David A. Candito, et al.. (2021). Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds. ACS Medicinal Chemistry Letters. 12(4). 653–661. 31 indexed citations
3.
Rodriguez‐Rivera, Frances P. & Samuel M. Levi. (2021). Unifying Catalysis Framework to Dissect Proteasomal Degradation Paradigms. ACS Central Science. 7(7). 1117–1125. 21 indexed citations
4.
Mennie, Katrina M., Brandon Vara, & Samuel M. Levi. (2020). Reductive sp3–sp2 Coupling Reactions Enable Late-Stage Modification of Pharmaceuticals. Organic Letters. 22(2). 556–559. 22 indexed citations
5.
Levi, Samuel M., et al.. (2020). Highly Selective β-Mannosylations and β-Rhamnosylations Catalyzed by Bis-thiourea. Journal of the American Chemical Society. 142(27). 11865–11872. 75 indexed citations
6.
Levi, Samuel M., et al.. (2018). Catalytic activation of glycosyl phosphates for stereoselective coupling reactions. Proceedings of the National Academy of Sciences. 116(1). 35–39. 63 indexed citations
7.
DeVorkin, Lindsay, Paul Kim, Michael S. Anglesio, et al.. (2017). Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian Carcinoma. Molecular Cancer Research. 15(3). 250–258. 56 indexed citations
8.
Hubbard-Lucey, Vanessa M., Yusuke Shono, Katie Maurer, et al.. (2014). Autophagy Gene Atg16l1 Prevents Lethal T Cell Alloreactivity Mediated by Dendritic Cells. Immunity. 41(4). 579–591. 84 indexed citations
9.
McAfee, Quentin, Zhihui Zhang, Arabinda Samanta, et al.. (2012). Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proceedings of the National Academy of Sciences. 109(21). 8253–8258. 321 indexed citations
10.
Levi, Samuel M., et al.. (2011). Palladium-Catalyzed C−CN Activation for Intramolecular Cyanoesterification of Alkynes. Organic Letters. 13(8). 1940–1943. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026